João Garcia da Fonseca, founder of biosurfit, has held the position of Chief Executive Officer and Chief Scientific Officer since the foundation of the company, in 2006. The appointment arises as a natural evolution for João Fonseca who will continue to be involved in the strategic business of biosurfit and continue as a key reference shareholder. Simultaneously, João Garcia da Fonseca will also accumulate the position of Chief Technology Officer at Inflammatix, a California based, molecular diagnostics company.
Biosurfit has appointed Rosa Santos, as the new Chief Executive Officer. Previously, Rosa Santos held the position of Chief Financial Officer since 2014, the year she has joined the company. Prior to biosurfit, Rosa Santos was at Staples Portugal where she held management positions in both financial, sales and project management direction.
"I am delighted to take up the role of CEO at biosurfit, a great challenge for me in an organisation I have become very passionate about over the past few years. I’m committed to building on the work that João has done!" commented Rosa Santos.
"The appointments announced today are important steps in the ongoing process of board renewal and the strategic development of the company in moving forward”, added João Garcia da Fonseca.